ArticleJournal of pediatric gastroenterology and nutrition2026
Safety and efficacy of weekly adalimumab 80 mg therapy in pediatric Crohn's disease.
Eyal Cohen-Sela et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it